Webinars

An overview of Dry Eye Disease and its impact on patients, with a focus on treatment considerations and how preservative-free, science-driven artificial tears can address multiple mechanisms of dry eye and support confident treatment decisions across patient types.

Vascular retinal pathology is frequency encountered in routine optometric care. As primary care providers, optometrists are in the unique position of being able to facilitate early detection and assist in subsequent management and treatment. This course will review retinal vascular anatomy to aid in the identification of different types of retinal hemorrhages. Furthermore, it will emphasize establishing differential diagnoses based on clinical presentation and discuss the appropriate blood work required to address possible underlying systemic disease. It will also provide a brief overview of other lab work related to the renal, hepatic, and pituitary system in the context of ocular disease.

This course addresses the most frustrating situations and challenges when offering orthokeratology in practice, providing practical solutions for smooth practice management and successful patient care.

This case-based course will walk participants through important aspects of retina cases.

Optometry has never been more fun – we have so many tools in our toolbox to help our dry eye patients. Long gone are dry eye management protocol that only acts to replenish the tear film through lubrication. Today, the spectrum of management of ocular surface diseases has expanded vastly to include the use of amniotic membranes, scleral lenses, intense pulse light (IPL), Radio Frequency (RF), lipiflow, biologics, amniotic membranes, LLLT, Plasma Pens and so much more. Our course will outline the thorough diagnostic process to understand the root of dry eye disease, how to incorporate these new technologies into your clinic, and how to determine the most appropriate treatment plan for your dry eye patients.

This course explores the relationship between the most common systemic conditions that appear to influence the onset and progression of glaucoma including cardiovascular diseases, diabetes, sleep apnea, and neurodegenerative diseases. The medications used in the treatment of systemic disease can also influence a patient in developing or being protected from developing glaucoma.